1.
|
Massano J, Regateiro FS, Januário G and
Ferreira A: Oral squamous cell carcinoma: review of prognostic and
predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 102:67–76. 2006. View Article : Google Scholar : PubMed/NCBI
|
2.
|
Scully C and Bagan J: Oral squamous cell
carcinoma: overview of current understanding of aetiopathogenesis
and clinical implications. Oral Dis. 15:388–399. 2009. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Kademani D, Bell RB, Bagheri S, et al:
Prognostic factors in intraoral squamous cell carcinoma: the
influence of histologic grade. J Oral Maxillofac Surg.
63:1599–1605. 2005. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Haddad RI and Shin DM: Recent advances in
head and neck cancer. N Engl J Med. 359:1143–1154. 2008. View Article : Google Scholar : PubMed/NCBI
|
5.
|
Glazer CA, Chang SS, Ha PK and Califano
JA: Applying the molecular biology and epigenetics of head and neck
cancer in everyday clinical practice. Oral Oncol. 45:440–446. 2009.
View Article : Google Scholar : PubMed/NCBI
|
6.
|
Eckert AW, Kappler M, Schubert J and
Taubert H: Correlation of expression of hypoxia-related proteins
with prognosis in oral squamous cell carcinoma patients. Oral
Maxillofac Surg. 16:189–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Oliveira LR and Ribeiro-Silva A:
Prognostic significance of immunohistochemical biomarkers in oral
squamous cell carcinoma. Int J Oral Maxillofac Surg. 40:298–307.
2011. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Nagpal JK and Das BR: Oral cancer:
reviewing the present understanding of its molecular mechanism and
exploring the future directions for its effective management. Oral
Oncol. 39:213–221. 2003. View Article : Google Scholar
|
9.
|
Moreno-Sánchez R, Rodriguez-Enriquez S,
Saavedra E, Marin-Hernández A and Gallardo-Pérez JC: The
bioenergetics of cancer: is glycolysis the main ATP supplier in all
tumor cells? Biofactors. 35:209–225. 2009.PubMed/NCBI
|
10.
|
Eckert AW, Lautner MH, Schütze A, Taubert
H, Schubert J and Bilkenroth U: Coexpression of hypoxia-inducible
factor-1α and glucose transporter-1 is associated with poor
prognosis in oral squamous cell carcinoma patients. Histopathology.
58:1136–1147. 2011.
|
11.
|
Ayala FR, Rocha RM, Carvalho KC, et al:
GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous
Cell Carcinoma. Molecules. 15:2374–2387. 2010. View Article : Google Scholar : PubMed/NCBI
|
12.
|
Denko NC: Hypoxia, HIF1 and glucose
metabolism in the solid tumour. Nat Rev Cancer. 8:705–713. 2008.
View Article : Google Scholar : PubMed/NCBI
|
13.
|
Ryu MH, Park HM, Chung J, Lee CH and Park
HR: Hypoxia-inducible factor-1alpha mediates oral squamous cell
carcinoma invasion via upregulation of alpha5 integrin and
fibronectin. Biochem Biophys Res Commun. 393:11–15. 2010.
View Article : Google Scholar : PubMed/NCBI
|
14.
|
Pérez-Sayáns M, Suárez-Peñaranda JM, Pilar
GD, Barros-Angueira F, Gándara-Rey JM and García-García A:
Hypoxia-inducible factors in OSCC. Cancer Lett. 313:1–8. 2011.
|
15.
|
Vaupel P and Mayer A: Hypoxia in cancer:
significance and impact on clinical outcome. Cancer Metastasis Rev.
26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
16.
|
Semenza GL: HIF-1: upstream and downstream
of cancer metabolism. Curr Opin Genet Dev. 20:51–56. 2010.
View Article : Google Scholar : PubMed/NCBI
|
17.
|
Keith B, Johnson RS and Simon MC: HIF1α
and HIF2α: sibling rivalry in hypoxic tumour growth and
progression. Nat Rev Cancer. 12:9–22. 2011.
|
18.
|
Lin PY, Yu CH, Wang JT, et al: Expression
of hypoxia-inducible factor-1 alpha is significantly associated
with the progression and prognosis of oral squamous cell carcinomas
in Taiwan. J Oral Pathol Med. 37:18–25. 2008. View Article : Google Scholar : PubMed/NCBI
|
19.
|
Koukourakis MI, Bentzen SM, Giatromanolaki
A, et al: Endogenous markers of two separate hypoxia response
pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase
9) are associated with radiotherapy failure in head and neck cancer
patients recruited in the CHART Randomized Trial. J Clin Oncol.
24:727–735. 2006. View Article : Google Scholar
|
20.
|
Kyzas PA, Stefanou D, Batistatou A and
Agnantis NJ: Hypoxia-induced tumor angiogenic pathway in head and
neck cancer: an in vivo study. Cancer Lett. 225:297–304. 2005.
View Article : Google Scholar : PubMed/NCBI
|
21.
|
Demasi AP, Costa AF, Altemani A, Furuse C,
Araújo NS and Araújo VC: Glucose transporter protein 1 expression
in mucoepidermoid carcinoma of salivary gland: correlation with
grade of malignancy. Int J Exp Pathol. 91:107–113. 2010. View Article : Google Scholar : PubMed/NCBI
|
22.
|
Fukuzumi M, Hamakawa H, Onishi A, Sumida T
and Tanioka H: Gene expression of GLUT isoforms and VHL in oral
squamous cell carcinoma. Cancer Lett. 161:133–140. 2000. View Article : Google Scholar : PubMed/NCBI
|
23.
|
Grover-McKay M, Walsh SA, Seftor EA,
Thomas PA and Hendrix MJ: Role for glucose transporter 1 protein in
human breast cancer. Pathol Oncol Res. 4:115–120. 1998. View Article : Google Scholar : PubMed/NCBI
|
24.
|
Krzeslak A, Wojcik-Krowiranda K, Forma E,
et al: Expression of GLUT1 and GLUT3 glucose transporters in
endometrial and breast cancers. Pathol Oncol Res. 18:721–728. 2012.
View Article : Google Scholar : PubMed/NCBI
|
25.
|
Ohba S, Fujii H, Ito S, et al:
Overexpression of GLUT-1 in the invasion front is associated with
depth of oral squamous cell carcinoma and prognosis. J Oral Pathol
Med. 39:74–78. 2010. View Article : Google Scholar : PubMed/NCBI
|
26.
|
Parente P, Coli A, Massi G, Mangoni A,
Fabrizi MM and Bigotti G: Immunohistochemical expression of the
glucose transporters Glut-1 and Glut-3 in human malignant melanomas
and benign melanocytic lesions. J Exp Clin Cancer Res. 27:342008.
View Article : Google Scholar
|
27.
|
Richardson SM, Knowles R, Tyler J,
Mobasheri A and Hoyland JA: Expression of glucose transporters
GLUT-1, GLUT-3, GLUT-9 and HIF-1alpha in normal and degenerate
human intervertebral disc. Histochem Cell Biol. 129:503–511. 2008.
View Article : Google Scholar : PubMed/NCBI
|
28.
|
Tian M, Zhang H, Nakasone Y, Mogi K and
Endo K: Expression of Glut-1 and Glut-3 in untreated oral squamous
cell carcinoma compared with FDG accumulation in a PET study. Eur J
Nucl Med Mol Imaging. 31:5–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
29.
|
Sandulache VC and Myers JN: Altered
metabolism in head and neck squamous cell carcinoma: an opportunity
for identification of novel biomarkers and drug targets. Head Neck.
34:282–290. 2012. View Article : Google Scholar : PubMed/NCBI
|
30.
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
31.
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: the metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009.PubMed/NCBI
|
32.
|
Macheda ML, Rogers S and Best JD:
Molecular and cellular regulation of glucose transporter (GLUT)
proteins in cancer. J Cell Physiol. 202:654–662. 2005. View Article : Google Scholar : PubMed/NCBI
|
33.
|
Wood IS and Trayhurn P: Glucose
transporters (GLUT and SGLT): expanded families of sugar transport
proteins. Br J Nutr. 89:3–9. 2003. View Article : Google Scholar : PubMed/NCBI
|
34.
|
Weiner MF, Miranda RN, Bardales RH, et al:
Diagnostic value of GLUT-1 immunoreactivity to distinguish benign
from malignant cystic squamous lesions of the head and neck in
fine-needle aspiration biopsy material. Diagn Cytopathol.
31:294–299. 2004. View
Article : Google Scholar
|
35.
|
Kunkel M, Reichert TE, Benz P, et al:
Overexpression of Glut-1 and increased glucose metabolism in tumors
are associated with a poor prognosis in patients with oral squamous
cell carcinoma. Cancer. 97:1015–1024. 2003. View Article : Google Scholar : PubMed/NCBI
|
36.
|
Kunkel M, Moergel M, Stockinger M, et al:
Overexpression of GLUT-1 is associated with resistance to
radiotherapy and adverse prognosis in squamous cell carcinoma of
the oral cavity. Oral Oncol. 43:796–803. 2007. View Article : Google Scholar : PubMed/NCBI
|